What does it cost to redispense unused medications in the pharmacy? A micro-costing study

dc.contributorHáskóli Íslandsen_US
dc.contributorUniversity of Icelanden_US
dc.contributor.authorBekker, Charlotte L.
dc.contributor.authorGardarsdottir, Helga
dc.contributor.authorEgberts, Antoine C. G.
dc.contributor.authorMolenaar, Hendrik A.
dc.contributor.authorBouvy, Marcel L.
dc.contributor.authorvan den Bemt, Bart J. F.
dc.contributor.authorHövels, Anke M.
dc.contributor.departmentLyfjafræðideild (HÍ)en_US
dc.contributor.departmentFaculty of Pharmaceutical Sciences (UI)en_US
dc.contributor.schoolHeilbrigðisvísindasvið (HÍ)en_US
dc.contributor.schoolSchool of Health Sciences (UI)en_US
dc.date.accessioned2020-04-30T14:04:56Z
dc.date.available2020-04-30T14:04:56Z
dc.date.issued2019-04-24
dc.descriptionPublisher's version (útgefin grein)en_US
dc.description.abstractBackground: Redispensing unused medications that have been returned to outpatient pharmacies by patients may reduce waste and healthcare costs. However, little is known regarding the extra costs associated with this process, nor the price level of medications for which this is economically beneficial. The objective of this study was to assess costs associated with redispensing unused medications in the pharmacy and the price level at which redispensing becomes cost-beneficial. Methods: A micro-costing study was conducted in four Dutch outpatient pharmacies for medications requiring room-temperature storage and requiring refrigeration. First, the pharmacy's necessary additional process steps and resources for redispensing were identified. Second, time required for each process step was simulated. Third, required resources were quantified by calculating labour, purchasing and overhead costs. Lastly, a model with different scenarios was constructed to calculate the price of a medication package at which redispensing becomes cost-beneficial. Results: Three main additional process steps for redispensing were identified: (1) pack medications with product quality indicators before dispensing, (2) assess quality of medications returned to the pharmacy (temperature storage, package integrity, expiry date) and (3a) restock medications fulfilling quality criteria or (3b) dispose of medications not fulfilling criteria. Total time required for all steps up to restock one medication package was on average 5.3 (SD ±0.3) and 6.8 (SD ±0.3) minutes for medications stored at room-temperature and under refrigeration, respectively, and associated costs were €5.54 and €7.61. Similar outcomes were found if a medication package would ultimately be disposed of. The price level primarily depended upon the proportion of dispensed packages returned unused to the pharmacy and fulfilling the quality criteria: if 5% is returned, of which 60% fulfils quality criteria, the price level was €101 per package for medications requiring room-temperature storage and €215 per package for those requiring refrigeration. However, if 10% is returned, of which 60% fulfils the quality criteria, the price level decreases to €53 and €109, respectively (arbitrary proportions). Conclusions: Redispensing unused medications in the pharmacy is at least cost-beneficial if applied to expensive medications.en_US
dc.description.versionPeer Revieweden_US
dc.format.extent243en_US
dc.identifier.citationBekker, C.L., Gardarsdottir, H., Egberts, A.C.G. et al. What does it cost to redispense unused medications in the pharmacy? A micro-costing study. BMC Health Services Research 19, 243 (2019). https://doi.org/10.1186/s12913-019-4065-6en_US
dc.identifier.doi10.1186/s12913-019-4065-6
dc.identifier.issn1472-6963
dc.identifier.journalBMC Health Services Researchen_US
dc.identifier.urihttps://hdl.handle.net/20.500.11815/1764
dc.language.isoenen_US
dc.publisherSpringer Science and Business Media LLCen_US
dc.relation.ispartofseriesBMC Health Services Research;19(1)
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHealth Policyen_US
dc.subjectCost-benefit ratioen_US
dc.subjectHealthcare economicsen_US
dc.subjectMedication wasteen_US
dc.subjectMicro-costingen_US
dc.subjectRedispensingen_US
dc.subjectHeilsuhagfræðien_US
dc.subjectHeilbrigðisstefnaen_US
dc.subjectLyfjaverslaniren_US
dc.subjectLyfen_US
dc.titleWhat does it cost to redispense unused medications in the pharmacy? A micro-costing studyen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dcterms.licenseOpen Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en_US

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Hleð...
Thumbnail Image
Nafn:
s12913-019-4065-6.pdf
Stærð:
999.83 KB
Snið:
Adobe Portable Document Format
Description:
Publisher´s version

Undirflokkur